Politics and PolicyGovernment & regulators

Bhumjaithai Party

Bhumjaithai Party is a Thai political party known for championing cannabis liberalisation, including the policy shift that led to Thailand’s 2022 cannabis decriminalisation. The party’s role is relevant to market analysis because political support helped create a rapid expansion of cannabis dispensaries, cultivation activity and related tourism before later regulatory tightening. It is a political organization rather than a company, so its profile belongs in policy and governance context rather than commercial operator mapping.

What this political actor actually represents

Bhumjaithai Party is the Thai political party that championed cannabis liberalisation, driving the June 2022 decriminalisation that removed cannabis from Thailand’s narcotics schedule. Led by Anutin Charnvirakul (who served as Public Health Minister 2019-2023), Bhumjaithai’s cannabis policy created an estimated 6,000+ dispensaries and significant cultivation activity before the Pheu Thai-led coalition government enacted cannabis flower rescheduling in November 2024. Bhumjaithai is a mid-sized coalition party with a rural and agricultural voter base in Northeastern Thailand.[, ]

Market relevance: Bhumjaithai’s cannabis policy was the enabling regulatory event for Thailand’s 2022-2024 cannabis market. The 2024 reschedule (cannabis flower back to restricted narcotics) while Bhumjaithai was no longer Public Health Ministry reflects the policy volatility when a single party’s political fortunes determine market-opening regulation. Future cannabis market developments in Thailand require assessing Bhumjaithai’s coalition positioning and electoral outcomes.[, ]

MoPH cannabis decriminalisation 2022; cannabis reschedule 2024; Thai cannabis industry coverage
Data as of: 2024-2026

Programs administered

Cannabis policy

2022 decriminalisation authorship

Bhumjaithai authored the Public Health Ministry gazette notification removing cannabis from Thailand’s Category 5 narcotics list in June 2022. This single regulatory act created the world’s first large-scale recreational-access cannabis market outside Western liberal democracies.

Agriculture

Cannabis cultivation promotion

Bhumjaithai promoted cannabis as a cash crop for Thai farmers, targeting Northeastern agricultural communities. The narrative linked cannabis liberalisation to rural income diversification and agricultural-sector modernisation.

Medical

Thai Tung Thong traditional medicine

Bhumjaithai promoted traditional Thai medicine applications of cannabis (Tung Thong formula) alongside modern medical-cannabis research. GPO (Government Pharmaceutical Organisation) was designated the exclusive state cannabis-extract manufacturer.

Coalition

2023 election and coalition positioning

Bhumjaithai won ~71 seats in the May 2023 election (down from earlier peak) and joined the Pheu Thai-led government coalition. Coalition partner status without Public Health Ministry control means reduced direct influence over cannabis regulatory direction.

Thailand cannabis regulatory timeline — key events

June 2022

Event

Cannabis removed from narcotics schedule (decriminalisation)

Political driver

Bhumjaithai (Anutin, MoPH)

2022-2024

Event

~6,000+ dispensaries opened; cultivation surge

Political driver

Market response to Bhumjaithai deregulation

May 2023

Event

General election; Pheu Thai wins, Bhumjaithai coalition partner

Political driver

Electoral outcome changes ministry control

November 2024

Event

Cannabis flower rescheduled back to restricted narcotics

Political driver

Pheu Thai-led government reversal

2025-2026

Event

Medical-cannabis-only framework development

Political driver

MoPH under new administration; GPO extraction monopoly maintained

MoPH gazette notifications; Thai cannabis industry coverage; GPO medical cannabis programme
Data as of: 2024-2026

Key drivers 2025-2026

Coalition cabinet positioning

Bhumjaithai’s role in the Pheu Thai-led coalition determines whether it recovers influence over Public Health Ministry and cannabis regulatory direction.

2027 election outcome scenario

If Bhumjaithai returns to government with Public Health Ministry control, cannabis re-liberalisation becomes a feasible policy scenario; opposition maintains restriction.

GPO medical-cannabis framework

Under the restricted framework, GPO’s exclusive medical-cannabis extraction position and MoPH clinical supply are the only legal commercial pathway for cannabis operators.

Dispensary legal transition period

Existing ~6,000 dispensaries require transition compliance under the rescheduled framework; enforcement timeline determines operator survival rate.

Watchpoints

Policy

Cannabis re-liberalisation scenario

Thai cannabis policy is structurally linked to election outcomes and coalition ministry allocations. A future government that returns Public Health Ministry to Bhumjaithai-aligned politicians could attempt a second liberalisation. Watch post-2027 election coalition negotiations for this scenario.

Legal

Dispensary enforcement actions

With cannabis flower rescheduled as restricted, ~6,000 dispensaries face legal uncertainty. MoPH and Thai FDA enforcement posture determines how quickly the market contracts and which operators survive under a medical-only framework.

Medical

GPO clinical-supply pipeline

GPO holds the exclusive medical-cannabis extraction licence. Its supply capacity to hospitals, clinics, and licensed medical-cannabis patients determines the size of the legal medical market that persists regardless of recreational-access political cycles.

Related Market profiles

Peers, parents, partners, agencies, and other Politics and Policy actors.

Reports featuring this profile

Related Market profiles

Bhumjaithai Party - Market Atlas · Insight